Showing results (31-40 of 49) with videos related to
Sort By:
Pageof 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 1998
The role of all-trans-retinoic acid (ATRA) treatment in newly-diagnosed acute promyelocytic leukemia patients aged > 60 yearsR Latagliata, G Avvisati, F Lo Coco, et al.Leukemia & Lymphoma|April 28, 2000
Acute myeloblastic leukemia secondary to myelodysplasia (MDS-AML): a comparison of remission induction with three drugs versus standard two-drugs inductionR Latagliata, M Breccia, A Pulsoni, et al.Leukemia & Lymphoma|January 1, 1993
Is recombinant human erythropoietin treatment in myelodysplastic syndromes worthwhile?M A Aloe Spiriti, M C Petti, R Latagliata, et al.Leukemia|April 1, 1993
Mitoxantrone, etoposide and intermediate-dose Ara-C (MEC): an effective regimen for poor risk acute myeloid leukemiaA Spadea, M C Petti, P Fazi, et al.Leukemia|August 26, 2006
Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular featuresM Breccia, G Avvisati, R Latagliata, et al.Leukemia|April 24, 1999
Outpatient management of acute promyelocytic leukemia after consolidation chemotherapyC Girmenia, R Latagliata, S Tosti, et al.Haematologica|September 8, 1999
Out-patient management of acute myeloid leukemia after consolidation chemotherapy. Role of a hematologic emergency unitC Girmenia, G Alimena, R Latagliata, et al.Annals of Hematology|July 2, 2003
High-dose hydroxyurea in the treatment of poor-risk myeloid leukemiasM C Petti, A Tafuri, R Latagliata, et al.La Clinica Terapeutica|May 26, 2010
[Budd-Chiari syndrome and splanchnic vein thrombosis: masked myeloproliferative neoplasms and JAK2V617F]A Fama, A Rago, F Gioiosa, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2005
Acute myelogenous leukemia in elderly patients not eligible for intensive chemotherapy: the dark side of the moonR Latagliata, V Bongarzoni, I Carmosino, et al.Pageof 5